ABSTRACT
BACKGROUND: Plants of the Myrcia genus have been widely used in folk medicine to treat various diseases, including cancer. Myrcia splendens species has a diverse chemical constitution, but the biological activities of its essential oil have not been well investigated. In this study to out the chemistry characterization of essential oil (EO) from the leaves of the species M. splendens from Brazil and evaluate cytotoxic effect in A549 lung cancer cells. METHODS: M. splendens EO was obtained by hydrodistillation and analyzed by Gas Chromatography-Mass Spectrometry (GC-MS). EO was isolated and evaluated for cellular viability in tumor cell lines by MTT assay. The evaluation of the formation of clones and the migratory capacity of the A549 cells treated with EO was done by the clonogenic assay and the wound healing assay. Morphological changes were observed in A549 cells by fluorescence using Phalloidin/FITC and DAPI. RESULTS: 22 compounds were identified in the chemical analysis of EO, corresponding to 88% of the sample. Major compounds were the sesquiterpenic hydrocarbons bicyclogermacrene (15.4%), germacrene D (8.9%) and E-caryophyllene (10.1%). The biological analysis of the EO showed high cytotoxic activity with an IC50 below 20 µg/ml in the THP-1, A549 and B16-F10 tumor cells. The treatment with EO reduced colony formation and inhibited the migratory capacity of A549 cells. Furthermore, apoptotic morphological changes in the nucleus and cytoplasm of A549 cells was observed after of treatment with EO. CONCLUSION: The findings of this study suggest that the M. splendens EO has cytotoxic compounds for the A549 lung cancer cells. Treatment with the EO decreased the colony formation and reduced the ability of lung cancer cells to migrate. Future studies may be used to isolate compounds from the EO for the study of lung cancer.
Subject(s)
Antineoplastic Agents , Lung Neoplasms , Myrtaceae , Oils, Volatile , Humans , Oils, Volatile/pharmacology , Oils, Volatile/chemistry , A549 Cells , Gas Chromatography-Mass Spectrometry , Antineoplastic Agents/pharmacology , Lung Neoplasms/drug therapyABSTRACT
Potential drug-eluting scaffolds of electrospun poly(acrylic acid-co-styrene sulfonate) P(AA-co-SS) in clonogenic assays using tumorigenic gastric and ovarian cancer cells were tested in vitro. Electrospun polymer nanofiber (EPnF) meshes of PAA and PSSNa homo- and P(AA-co-SS) copolymer composed of 30:70, 50:50, 70:30 acrylic acid (AA) and sodium 4-styrene sulfonate (SSNa) units were performed by electrospinning (ES). The synthesis, structural and morphological characterization of all EPnF meshes were analyzed by optical and electron microscopy (SEM-EDS), infrared spectroscopy (FTIR), contact angle, and X-ray diffraction (XRD) measurements. This study shows that different ratio of AA and SSNa of monomers in P(AA-co-SS) EPnF play a crucial role in clonogenic in vitro assays. We found that 50:50 P(AA-co-SS) EPnF mesh loaded with antineoplastic drugs can be an excellent suppressor of growth-independent anchored capacities in vitro assays and a good subcutaneous drug delivery system for chemotherapeutic medication in vivo model for surgical resection procedures in cancer research.
ABSTRACT
RESUMEN Introducción: Desde los inicios de la medicina antigua, las plantas han sido utilizadas como tratamiento en diversas enfermedades incluyendo las de naturaleza infecto-contagiosa y el cáncer. Son numerosos los informes sobre las propiedades biológicas del género Phyllanthus. Objetivo: Evaluar la actividad citotóxica y antiproliferativa de un extracto acuoso de Phyllanthus comosus en tres líneas celulares, dos de origen tumoral (SiHa y HeLa) y una no tumoral (Vero). Métodos: La actividad citotóxica se evaluó mediante el método del MTT y la capacidad antiproliferativa mediante el ensayo de detección de inhibición de colonias o clonogénico. Se tuvieron en cuenta valores como la concentración citotóxica media (CC50), índice selectivo y porcentaje de disminución de la proliferación celular. Resultados: En el ensayo de citotoxicidad se obtuvieron CC50 similares para ambas líneas tumorales; mientras que el valor para la línea Vero resultó tres veces menos tóxico, con valores de índice de selectividad mayor que tres. El ensayo clonogénico demostró inhibición de la proliferación en las líneas tumorales, mientras que en células Vero no se observó inhibición de la capacidad de formación de colonias. Conclusiones: El extracto de P. comosus es más citotóxico para las líneas tumorales SiHa y HeLa que para las células Vero, no tumorales. Además, la inhibición de la formación de clonos celulares en ambas líneas tumorales evidencia su acción antiproliferativa y selectiva, lo que argumenta su potencialidad antitumoral in vitro
ABSTRACT Introduction: Ever since the onset of ancient medical practice, plants have been used to treat a variety of conditions, including infectious communicable diseases and cancer. A large number of reports are available about the biological properties of the genus Phyllantus. Objective: Evaluate the cytotoxic and antiproliferative activity of an aqueous extract of Phyllanthus comosus on three cell lines: two of tumoral origin (SiHa and HeLa) and one of non-tumoral origin (Vero). Methods: Cytotoxic activity was evaluated by the MTT method, and antiproliferative capacity by colony inhibition detection or clonogenic assay. Mean cytotoxic concentration (CC50), selective index and cell proliferation reduction percentage were some of the values taken into account. Results: The cytotoxicity assay obtained similar CC50 values for both tumor cell lines, whereas the value for the Vero line was three times less toxic, with a selectivity index above three. The clonogenic assay revealed proliferation inhibition in the tumor cell lines, whereas no inhibition of colony forming capacity was observed in Vero cells. Conclusions: The P. comosus extract is more cytotoxic for tumoral cell lines SiHa and HeLa than for non-tumor Vero cells. Additionally, inhibition of the formation of cell clones in both tumor cell lines is evidence of its antiproliferative and selective action, substantiating its in vitro antitumor potential.
ABSTRACT
BACKGROUND: Melanoma is a malignant cancer that affects melanocytes and is considered the most aggressive skin-type cancer. The prevalence for melanoma cancer for the last five year is about one million cases. The impact caused of this and other types of cancer, revel the importance of research into potential active compounds. The natural products are an important source of compounds with biological activity and research with natural products may enable the discovery of compounds with potential activity in tumor cells. METHODS: The Sulforhodamine B was used to determine cell density after treatment with lawsone derivatives. Apoptosis and necrosis were analyzed by flow cytometer. Morphological changes were observed by fluorescence using the Phalloidin/FITC and DAPI stains. The clonogenic and wound healing assays were used to analyze reduction of colonies formation and migratory capacity of melanoma cells, respectability. RESULTS: In pharmacological screening, seven compounds derived from lawsone were considered to have high cytotoxic activity (GI > 75%). Three compounds were selected to assess the inhibitory concentration for 50% of cells (IC50), and the compound 9, that has IC50 5.3 µM in melanoma cells, was selected for further analyses in this cell line. The clonogenic assay showed that the compound is capable of reducing the formation of melanoma colonies at 10.6 µM concentration. The compound induced apoptotic morphological changes in melanoma cells and increased by 50% the cells dying from apoptosis. Also, this compound reduced the migratory capacity of melanoma cells. CONCLUSIONS: The results of this study showed that the evaluated lawsone derivatives have potential activity on tumor cells. The compound 9 is capable of inducing cell death by apoptosis in melanoma cells (B16F10).
Subject(s)
Melanoma/drug therapy , Naphthoquinones/pharmacology , Skin Neoplasms/drug therapy , Animals , Apoptosis/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Drug Screening Assays, Antitumor , Glycosides/chemistry , Humans , Melanoma/pathology , Mice , Naphthoquinones/chemistry , Naphthoquinones/therapeutic use , Skin Neoplasms/pathology , Tumor Stem Cell AssayABSTRACT
INTRODUCTION: Clonogenic assay evaluates the potential of cells to undergo division or generate clones following treatment with a chemical or other agent, thereby allowing the evaluation of cytotoxic and/or antiproliferative effects. Clonogenic assay analysis using traditional methods tends to be time-consuming and yield inconsistent results, whereas results from analyses conducted using automated image processing methods may be misleading or subject to misinterpretation. Thus, the aim of this work was to validate and demonstrate the applicability of a recently developed software. METHODS: Repeatability of measurements was evaluated by comparing results from 10 replicate images from a single well. To evaluate the viability of the software, results were compared with those obtained from manual counting, crystal violet optical density, and up-to-date automated methods. A clonogenic index was experimentally developed using the individual area occupied by colonies, while clone stratification was used to differentiate between antiproliferative and cytotoxic effects. RESULTS: The developed software showed to be a reliable and consistent tool for clonogenic assay evaluation, presenting a repeatability mean error of 0.79% for the number of colonies and 0.89% for the total area of colonies, as well as exhibiting a significant correlation (p < 0.05) with results obtained from widely adopted gold standard methods. The software was also able to detect an appropriate dose-dependent effect as well as a predominant cytotoxic effect of vincristine on MCF-7 cells and calculate the clonogenic index. DISCUSSION: Therefore, this software is adequate for the analysis of clonogenic assay images, differentiating between cytotoxic and antiproliferative trends.
Subject(s)
Image Processing, Computer-Assisted/methods , Intravital Microscopy/methods , Software , Tumor Stem Cell Assay/methods , Antineoplastic Agents, Phytogenic/pharmacology , Cell Count/methods , Cell Proliferation/drug effects , Drug Screening Assays, Antitumor/methods , Humans , MCF-7 Cells , Reproducibility of Results , Vincristine/pharmacologyABSTRACT
A series of benzo[g]benzothiazolo[2,3-b]quinazoline-7,12-quinones were prepared from 2-acylnaphthohydroquinones and 2-aminobenzothiazoles and were evaluated for their in vitro antiproliferative activity. After screening using the MTT reduction assay, their IC50 values were calculated on a panel of cancer cells (T24, DU-145, MCF-7). Current standard anticancer drugs were included as control, and their calculated IC50 values were 7.8 and 23.5 µM for 5-fluorouracil and tamoxifen, respectively. Non-cancer cells (AG1523) were included to assess cancer cell sensitivity and drug selectivity. Four members of the series, with IC50 values from 0.11 to 2.98 µM, were chosen for further assays. The selected quinones were evaluated regarding their effects on cancer cell proliferation (clonogenic assay) and on Hsp90 and poly(ADPribose)polymerase (PARP) protein integrity. The most active compound (i.e., 15) substantially inhibited colony forming unit (CFU) formation at 0.25 µM. In the presence of ascorbate, it induced an oxidative cleavage of Hsp90 but had no effect on PARP protein integrity. In an in vivo animal model, it discreetly increased the mean survival time (m.s.t.) of tumor-bearing mice. In light of these results, compound 15 represents a potential lead-molecule to be further developed.
Subject(s)
Antineoplastic Agents , Cell Proliferation/drug effects , HSP90 Heat-Shock Proteins , Neoplasm Proteins , Neoplasms, Experimental , Quinazolines , Animals , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Ascorbic Acid , HSP90 Heat-Shock Proteins/antagonists & inhibitors , HSP90 Heat-Shock Proteins/metabolism , Humans , MCF-7 Cells , Mice , Neoplasm Proteins/antagonists & inhibitors , Neoplasm Proteins/metabolism , Neoplasms, Experimental/drug therapy , Neoplasms, Experimental/metabolism , Neoplasms, Experimental/pathology , Quinazolines/chemical synthesis , Quinazolines/chemistry , Quinazolines/pharmacology , Xenograft Model Antitumor AssaysABSTRACT
BACKGROUND: Associating paclitaxel (PTX) to doxorubicin (DXR) is one of the main chemotherapy strategies for breast cancer (BC) management. Protocols currently available consist in administering both drugs on their maximum tolerated dose, not taking into account the possible differences in efficacy due to their combination ratio. In the present study, the short and long-term cytotoxic effects as well as migratory effects of PTX, DXR, and its combinations at 10:1; 1:1 and 1:10 PTX:DXR molar ratios either free or co-encapsulated in liposomes were evaluated against three human BC cell lines (MDA-MB-231, MCF-7, and SKBR-3). METHOD: The MTT assay was used to screen for synergy or antagonism between PTX and DXR and the combination index value was calculated using the CalcuSyn software. Nuclear morphological alterations were evaluated by staining the cells with Hoescht 33342. The investigation of senescence and clonogenicity of BC cell lines exposed to different treatments was also studied. In addition, the ability of these cells to migrate was assessed. RESULTS: Taken together, the results presented herein allow us to suggest that there is no benefit in enhancing the PTX concentration above that of DXR in the combination for any of the three cell lines tested. CONCLUSION: The developed liposomes co-encapsulating PTX and DXR in different molar ratios retained the biological properties of the mixture of free drugs and are valuable for planning new therapeutic strategies.
ABSTRACT
ETHNOPHARMACOLOGICAL RELEVANCE: Lafoensia pacari A. St.-Hil., belonging to the family Lythraceae and popularly known as 'dedaleira' and 'mangava-brava,' is a native tree of the Brazilian Cerrado, and its barks have been traditionally used as a tonic to treat inflammatory conditions, particularly related to gastric ulcers, wounds or fevers and various types of cancer. AIM OF THE STUDY: We have previously demonstrated the apoptogenic effects of the methanolic extract of L. pacari using various cancer cell lines. In the present study, this extract has been partitioned into fractions to identify the components that might be responsible for the apoptogenic effects using HRT-18 cells, which have been previously demonstrated to be sensitive to this extract. MATERIALS AND METHODS: A standard methanolic extract was prepared and fractionated by centrifugal partition chromatography. The fractions were submitted to cytotoxicity and clonogenic assays to monitor the effects in parallel with LC-DAD-MS and statistical analyses to suggest the potential bioactive compounds. RESULTS: Besides ellagic acid, the primary constituent of the plant and also the biomarker of the species, punicalin, pedunculagin and punicalagin isomers, catechin and ellagic acid derivatives were putatively identified. CONCLUSIONS: The barks of L. pacari are rich in ellagic acid and various hydrolysable tannins, some of which were reported for the first time in this species, such as punicalagin and ellagitannins. This mixture of substances had the ability to kill proliferating cells and abrogate the growth of clonogenic cells in a similar manner shown by the methanolic extract of our previous study. The collective data reported herein suggest that the biological activities of the L. pacari barks used by population to treat cancer conditions are due to the apoptogenic effects promoted by a mixed content of ellagitannins.
Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Lythraceae , Plant Extracts/pharmacology , Animals , Antineoplastic Agents, Phytogenic/analysis , Cell Line , Cell Line, Tumor , Cell Survival/drug effects , Colonic Neoplasms/metabolism , Humans , Metabolomics , Mice , Phytochemicals/analysis , Phytochemicals/pharmacology , Plant Bark , Plant Extracts/analysisABSTRACT
AIM: The current work shows a new synthetic methodology to obtain 21 naphthoquinones that have been evaluated against oral cavity cancer. The compounds were obtained by a three-component reaction involving lawsone, dimedone and aromatic aldehydes catalyzed by lithium chloride under microwave irradiation to produce families of 1,4- and 1,2-naphthoquinones. RESULTS: A clonogenic assay was performed on SCC9 cell line cultures with all compounds, revealing five very active compounds. In the 3,4,5-dimethylthiazol-2,5-diphenyltetrazolium bromide cell viability assay using three different cell lines (SCC9, SCC4 and SCC25), 8c had an average IC50 of approximately 1.45 µM capable of reducing tumor cell viability, approximately 90-times higher than carboplatin. CONCLUSION: Therefore, the xanthene-naphthoquinone derivatives show promising bioactivity for oral cavity cancer treatment.
Subject(s)
Antineoplastic Agents/chemistry , Xanthenes/chemistry , Animals , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/pharmacology , Carboplatin/pharmacology , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Cell Line, Tumor , Cell Survival/drug effects , Erythrocytes/cytology , Erythrocytes/drug effects , Erythrocytes/metabolism , Hemolysis/drug effects , Humans , Mice , Mouth Neoplasms/metabolism , Mouth Neoplasms/pathology , NIH 3T3 Cells , Naphthoquinones/chemistry , Structure-Activity Relationship , Xanthenes/chemical synthesis , Xanthenes/pharmacologyABSTRACT
Patients receiving chemotherapy treatment in Santiago de Cuba traditionally use water extracts from Trichilia hirta roots. The study aim was to evaluate the immunorestorative and cytotoxic activity of water extracts from Trichilia hirta root. Administration of root water extract increased the total and differential leukocyte counts in inmunosupressed Balb/c mice. Thymus weight recovered significantly as well as bone marrow cellularity. Moreover, water extract (125 ug/mL) showed selective cytotoxicity against cancer cells T-47D and SK-mel-3 in comparison with non-cancer cells (Vero). The results indicate that Trichilia hirta has significant immunorestorative effects in vivo and selective cytotoxicity in vitro. Therefore, it might be a promising alternative for cancer therapy(AU)
Pacientes bajo tratamiento quimioterpéutico tradicionalmente usan extractos acuosos de raíz de Trichilia hirta en Santiago de Cuba. El objetivo de este estudio fue evaluar la actividad inmunorestauradora y citotóxica de extractos acuosos de raíz de Trichilia hirta. La administración del extracto acuoso de raíz incrementó los conteos globales y diferenciales de leucocitos en ratones inmunodeprimidos. El peso del timo, así como, la celularidad de la médula ósea se recuperaron significativamente. Además, el extracto acuoso (125 ug/mL) mostró citotoxicidad selectiva contra las células tumorales T-47D y SK-mel-3 en comparación con la línea no tumoral (Vero). Los resultados indican que Trichilia hirta posee significativos efectos inmunorestauradores in vivo y citotoxicidad selectiva, por lo cual podría ser una promisoria alternativa para la terapia del cáncer(AU)
Subject(s)
Humans , Female , Meliaceae/toxicity , Combined Modality Therapy , Drug Therapy, Combination , Tumor Stem Cell Assay , Polysaccharides , Cytotoxicity Tests, ImmunologicABSTRACT
Patients receiving chemotherapy treatment in Santiago de Cuba traditionally use water extracts from Trichilia hirta roots. The study aim was to evaluate the immunorestorative and cytotoxic activity of water extracts from Trichilia hirta root. Administration of root water extract increased the total and differential leukocyte counts in inmunosupressed Balb/c mice. Thymus weight recovered significantly as well as bone marrow cellularity. Moreover, water extract (125 ug/mL) showed selective cytotoxicity against cancer cells T-47D and SK-mel-3 in comparison with non-cancer cells (Vero). The results indicate that Trichilia hirta has significant immunorestorative effects in vivo and selective cytotoxicity in vitro. Therefore, it might be a promising alternative for cancer therapy.
Pacientes bajo tratamiento quimioterapéutico tradicionalmente usan extractos acuosos de raíz de Trichilia hirta en Santiago de Cuba. El objetivo de este estudio fue evaluar la actividad inmunorestauradora y citotóxica de extractos acuosos de raíz de Trichilia hirta. La administración del extracto acuoso de raíz incrementó los conteos globales y diferenciales de leucocitos en ratones inmunodeprimidos. El peso del timo, así como, la celularidad de la médula ósea se recuperaron significativamente. Además, el extracto acuoso (125 ug/mL) mostró citotoxicidad selectiva contra las células tumorales T-47D y SK-mel-3 en comparación con la línea no tumoral (Vero). Los resultados indican que Trichilia hirta posee significativos efectos inmunorestauradores in vivo y citotoxicidad selectiva, por lo cual podría ser una promisoria alternativa para la terapia del cáncer.